MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

74 hedge funds and large institutions have $166M invested in Marinus Pharmaceuticals, Inc in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+5
Holders Change %
+7.25%
% of All Funds
1.19%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
19
Increased
33
Reduced
11
Closed
13
Calls
$5.33M
Puts
$1.08M
Net Calls
+$4.24M
Net Calls Change
+$1.01M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$14M
2
EAM
2
Eventide Asset Management
Massachusetts
$12.5M
3
SCM
3
Suvretta Capital Management
New York
$19.2M
4
Millennium Management
4
Millennium Management
New York
$4.31M
5
OM
5
Opaleye Management
Massachusetts
$3.29M

Top Sellers

1
VA
1
VR Adviser
New York
$7.05M
2
6CM
2
683 Capital Management
New York
$358K
3
GPCM
3
Granite Point Capital Management
Massachusetts
$0
4
AG
4
Artal Group
Luxembourg
$0
5
E
5
Ergoteles
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PAI
76
Palo Alto Investors
California
– -$208K -31,330 Closed
GCP
77
GSA Capital Partners
United Kingdom
– -$205K -30,856 Closed
Walleye Trading
78
Walleye Trading
New York
– -$117K -17,669 Closed
LP
79
LMR Partners
United Kingdom
– -$117K -17,565 Closed
DU
80
Delphia (USA)
Ontario, Canada
– -$86K -12,973 Closed
CC
81
Corton Capital
Ontario, Canada
– -$85K -12,736 Closed
CI Investments Inc
82
CI Investments Inc
Ontario, Canada
– -$17K -2,500 Closed
QT
83
Quantbot Technologies
New York
– -$11K -1,800 Closed
AA
84
Ancora Advisors
Ohio
– -$3K -400 Closed
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
– -$858 -129 Closed
1 2 3
4